D. Castle

发表

The Effectiveness and Cost of an Intervention to Increase the Provision of Preventive Care in Community Mental Health Services: Protocol for a Cluster-Randomized Controlled Trial

C. Oldmeadow, Caitlin Fehily, Emma McKeon, 2022, International journal of environmental research and public health.

Participatory Methods to Engage Health Service Users in the Development of Electronic Health Resources: Systematic Review (Preprint)

K. Gray, D. Castle, G. Moore, 2018 .

Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments

D. Castle, J. Carroll, B. Wilson, 2014 .

Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment Trial

P. Kelly, A. Baker, A. Turner, 2022, Frontiers in Psychiatry.

Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials

D. Castle, D. Thompson, Chantal F. Ski, 2022, Psychological Medicine.

Using financial incentives to improve health service engagement and outcomes of adults experiencing homelessness: A scoping review of the literature.

A. Bani-Fatemi, D. Castle, A. Durbin, 2022, Health & social care in the community.

A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs

Chaomei Chen, L. Mallet, Y. Khazaal, 2022, European Neuropsychopharmacology.

The value of compassionate support to address smoking: A qualitative study with people who experience severe mental illness

P. Kelly, A. Baker, A. Turner, 2022, Frontiers in Psychiatry.

Protocol for a systematic review of interventions targeting mental health, cognition or psychological well-being among individuals with long COVID

Eric E Brown, D. Castle, D. Thompson, 2022, BMJ Open.

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2022, CNS Drugs.

Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study.

D. Castle, E. Chan, I. Wong, 2022, Journal of affective disorders.

Peer‐facilitated interventions for improving the physical health of people with schizophrenia spectrum disorders: systematic review and meta‐analysis

B. Druss, D. Castle, S. Agarwal, 2022, The Medical journal of Australia.

A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs

Chaomei Chen, L. Mallet, Y. Khazaal, 2022, European Neuropsychopharmacology.

Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?

D. Castle, V. Versace, C. Samorinha, 2022, The Medical journal of Australia.

A call for the increased education and use of behaviour change techniques in mental health services

D. Castle, S. Rossell, Caitlin Liddelow, 2022, General Hospital Psychiatry.

A systematic review of gender-responsive and integrated substance use disorder treatment programs for women with co-occurring disorders

M. Potenza, S. Tyagi, T. George, 2022, The American journal of drug and alcohol abuse.

Family History Tools in Primary Care: Does One Size Fit All?

D. Castle, J. Grimshaw, J. Little, 2012, Public Health Genomics.

Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation

L. Lemyre, D. Castle, B. Potter, 2016, BMC Medical Genomics.

Public attitudes towards genomic risk profiling as a component of routine population screening.

J. Little, L. Lemyre, D. Castle, 2013, Genome.

Title: Personalized medicine and genome-based treatments: why personalized medicine ≠ individualized treatments Short title: Personalized medicine ≠ individualized treatments

D. Castle, J. Carroll, H. Etchegary, 2014 .

Screening, assessment and diagnosis in the eating disorders: findings from a rapid review

M. Tiggemann, L. Vartanian, N. Foroughi, 2022, Journal of eating disorders.

The impact of COVID‐19 on the mental health workforce: A rapid review

D. Castle, Z. Jenkins, Ravi Bhat, 2022, International journal of mental health nursing.

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

A. Nierenberg, J. Cryan, D. Castle, 2023, Pilot and Feasibility Studies.

Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial

A. Nierenberg, J. Cryan, D. Castle, 2023, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

R. Lam, S. Kennedy, R. McIntyre, 2022, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Embedding lived experience into mental health academic research organizations: Critical reflections

D. Castle, S. Wells, M. Slade, 2022, Health expectations : an international journal of public participation in health care and health policy.

Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation

L. Lemyre, D. Castle, B. Potter, 2016, BMC Medical Genomics.

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.

P. Kelly, A. Turner, R. Borland, 2023, The Australian and New Zealand journal of psychiatry.

Interventions to support mental health in people with long COVID: a scoping review

D. Castle, C. Ski, A. Clifton, 2023, BMC Public Health.

Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping Review

D. Fitzpatrick-Lewis, J. Cafazzo, D. Castle, 2023, JMIR diabetes.

Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder

Jamie D. Feusner, D. Castle, N. Ledwos, 2022, Journal of psychopharmacology.

Clozapine shared care: mental health services and GPs working together for better outcomes for people with schizophrenia

D. Castle, D. Siskind, Shoshana Buckhalter, 2022, The Medical journal of Australia.

How does a family history of psychosis influence the risk of methamphetamine‐related psychotic symptoms: Evidence from longitudinal panel data

P. Kelly, A. Turner, P. Clare, 2023, Addiction.